Beverly is a pharmaceutical scientist and registered pharmacist with over 10 years research experience in the areas of crystallization, physical chemistry, preformulation, and drug delivery. She possesses a broad knowledge of pharmaceutical development, coupled with a patient-centered drug delivery perspective. She is a skilled cross-functional project team member who is able to communicate effectively in a multidisciplinary environment.
Beverly graduated from the Philadelphia College of Pharmacy (University of the Sciences) with a B.S. degree in Pharmacy and a minor in Mathematics. Subsequently, she earned her M.S. and Ph.D. degrees in Pharmaceutics from the University of Michigan under the direction of Dr. Naír Rodríguez-Hornedo and Dr. Gordon Flynn. Her dissertation studied the effects of polymers on the crystallization of carbamazepine and indomethacin polymorphs from aqueous and organic solutions.
Beverly joined Aventis Pharmaceuticals in 2001 as a Research Investigator in the Discovery Pharmaceutics area. She remained with sanofi-aventis as a Principal Research Investigator until 2012. During her tenure, she managed projects at the interface between discovery and pharmaceutical development, with responsibilities including project team leadership, preformulation studies, physical form selection, physico-chemical characterization, biopharmaceutical evaluation, early formulation development, and candidate risk assessment.